SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-21-007899
Filing Date
2021-06-15
Accepted
2021-06-15 20:54:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 28150
2 GRAPHIC g175698g55r13.jpg GRAPHIC 3569
  Complete submission text file 0000950123-21-007899.txt   34142
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)